CK Life Sciences International Holdings (STU:LSI) Operating Margin %: -3.47% (As of Dec. 2025)


STU:LSI CK Life Sciences International Holdings Inc STU:LSI
34 GF Score
Price €0.07
GF Value €0.08
! 5 Warning Signs
View Full Analysis

What is CK Life Sciences International Holdings Operating Margin %?

CK Life Sciences International Holdings STU:LSI -4.35% 34 Operating Margin % is -3.47% as of Dec. 2025. GuruFocus rates STU:LSI with a GF Score™ of 34/100 and a GF Value™ of €0.08. The stock has 5 warning signs investors should review. Among 945 Biotechnology companies, CK Life Sciences International Holdings ranks better than 71.22% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. CK Life Sciences International Holdings's Operating Income for the six months ended in Dec. 2025 was €-10.7 Mil. CK Life Sciences International Holdings's Revenue for the six months ended in Dec. 2025 was €307.8 Mil. Therefore, CK Life Sciences International Holdings's Operating Margin % for the quarter that ended in Dec. 2025 was -3.47%.

The historical rank and industry rank for CK Life Sciences International Holdings's Operating Margin % or its related term are showing as below:

STU:LSI' s Operating Margin % Range Over the Past 10 Years
Min: -2.42   Med: 4.34   Max: 7.31
Current: -2.42


STU:LSI's Operating Margin % is ranked better than
71.22% of 945 companies
in the Biotechnology industry
Industry Median: -86.77 vs STU:LSI: -2.42

CK Life Sciences International Holdings's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

CK Life Sciences International Holdings's Operating Income for the six months ended in Dec. 2025 was €-10.7 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €-14.4 Mil.

Warning Sign:

CK Life Sciences International Holdings Inc has recorded a loss in operating income at least once over the past 3 years.


CK Life Sciences International Holdings  (STU:LSI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


CK Life Sciences International Holdings Operating Margin % Related Terms


CK Life Sciences International Holdings Operating Margin % Historical Data

* Premium members only.

The historical data trend for CK Life Sciences International Holdings's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CK Life Sciences International Holdings Operating Margin % Chart

CK Life Sciences International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.46 4.59 4.21 1.40 -2.42

CK Life Sciences International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 5.78 -2.60 -1.29 -3.47

STU:LSI vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, CK Life Sciences International Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Operating Margin % distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Operating Margin % falls into.


STU:LSI
34GF Score
CK Life Sciences International Holdings Inc STU:LSI
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CK Life Sciences International Holdings Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

CK Life Sciences International Holdings's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-14.381 / 593.812
=-2.42 %

CK Life Sciences International Holdings's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-10.685 / 307.805
=-3.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -3.47% mean?
CK Life Sciences International Holdings (STU:LSI) has a Operating Margin % of -3.47% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on CK Life Sciences International Holdings and its competitors. According to the industry distribution chart, CK Life Sciences International Holdings ranks #272 out of 945 companies in the Biotechnology industry, placing it in the top 28.8%.
Is CK Life Sciences International Holdings' Operating Margin % too high?
CK Life Sciences International Holdings' current Operating Margin % is -3.47%. Based on the distribution chart, CK Life Sciences International Holdings ranks #272 out of 945 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CK Life Sciences International Holdings ranks #272 out of 945 companies for Operating Margin %. This puts CK Life Sciences International Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on CK Life Sciences International Holdings and its competitors. CK Life Sciences International Holdings's current Operating Margin % is -3.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (STU:LSI) has a current Operating Margin % of -3.47%. The stock's GF Value™ is €0.08, compared to a current price of €0.07 — trading 17.5% below its estimated fair value. The current Operating Margin % is -3.47%. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For CK Life Sciences International Holdings (STU:LSI), the current Operating Margin % is -3.47% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CK Life Sciences International Holdings (STU:LSI) Overvalued in 2026?

Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued. The current stock price of €0.07 is trading 17.5% below its estimated GF Value™ of €0.08.

Key valuation signals for STU:LSI:

  • Operating Margin %: -3.47%
  • GF Value™: €0.08 vs. price of €0.07 (17.5% below fair value)
  • GF Score™: 34/100 with 5 warning signs

No single metric tells the full story. See the STU:LSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CK Life Sciences International Holdings Business Description

Other Exchanges 00775:Hong Kong
Address 2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score

Get the complete analysis for STU:LSI

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.08
GF Value